The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
- 20 July 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (21), 4588-4590
- https://doi.org/10.1200/jco.2005.12.245
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomasEuropean Journal of Cancer, 2005
- The sentinel node procedure in patients with melanomaEuropean Journal of Surgical Oncology, 2004
- Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanomaEuropean Journal of Surgical Oncology, 2004
- High incidence of in-transit metastases after sentinel node biopsy in patients with melanomaBritish Journal of Surgery, 2004
- Lymphatic Mapping in the Molecular EraAnnals of Surgical Oncology, 2004
- Factors Affecting Survival After Complete Response to Isolated Limb Perfusion in Patients With In-Transit MelanomaAnnals of Surgical Oncology, 2001
- Are Locoregional Cutaneous Metastases in Melanoma Predictable?Annals of Surgical Oncology, 1999
- Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trialThe Lancet, 1998
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992
- Natural history and selective management of in transit melanomaJournal of Surgical Oncology, 1990